Board Meeting20 Oct 2026, 07:30 pm
Aptus Pharma Board Approves Unaudited Financial Results
AI Summary
Aptus Pharma Ltd announced that its Board of Directors, in a meeting held on October 20, 2026, approved the unaudited standalone financial results for the half year ended September 30, 2026. The Statutory Auditors have issued a Limited Review Report on these results. Additionally, the company informed that the trading window for designated persons will open on October 23, 2026.
Key Highlights
- Board approved unaudited financial results for H1 FY27.
- Limited Review Report from Statutory Auditors is enclosed.
- Trading window to open on October 23, 2026.
- Meeting held on October 20, 2026.
- Results are standalone and unaudited.
Price Impact
More from APPL